Pharmaron Beijing Co., Ltd. (SZSE:300759) acquired Aesica Pharmaceuticals Limited from Recipharm AB (publ) on January 10, 2022. Goetzpartners securities acted as exclusive financial advisor to Pharmaron, and O'Melveny acted as legal advisor. Results Healthcare acted as exclusive financial advisor to Recipharm and Addleshaw Goddard acted as legal advisor.

Pharmaron Beijing Co., Ltd. (SZSE:300759) completed the acquisition of Aesica Pharmaceuticals Limited from Recipharm AB (publ) on January 10, 2022.